Physician profile
Pardeep Brar
NPI 1538153713
$1,257.37
in general payments reported to CMS, 2019-2025
7 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $93.03 · 2021: $271 · 2022: $137 · 2023: $485 · 2024: $74.73 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398 · Travel and Lodging: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.39 |
| Travel and Lodging | $358.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $551.38 | 2020-2025 | Mavyret |
| Ovesco Endoscopy USA, INC. | $358.70 | 2023 | |
| Boston Scientific Corporation | $137.91 | 2023-2024 | Exalt Model D |
| Madrigal Pharmaceuticals | $104.52 | 2025 | Rezdiffra |
| Nobel Biocare USA | $76.14 | 2021 | |
| Gilead Sciences, INC. | $16.04 | 2022 | |
| Braintree Laboratories, INC. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pardeep Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.